Private company
BIOTECHNOLOGY VALUE FUND L P
American investment advice company based in San Francisco. Summary from the record
Last updated Oct 21, 2026.
Overview
Corporate structure
BIOTECHNOLOGY VALUE FUND L P sits at the top of its group. 107 entities, 6 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- BIOTECHNOLOGY VALUE FUND L P DE
- 4D Molecular Therapeutics, Inc. Stake · Emeryville, California
- 89bio, Inc. Stake · San Francisco, California
- AC Immune SA Stake · V8
- Aclaris Therapeutics, Inc. Stake · Wayne, Pennsylvania, United States
- Alector (United States) Stake · South San Francisco, California
- Allakos Inc. Stake · San Carlos, California, United States
- Alpine Immune Sciences Stake · Boulder, Colorado, United States
- AN2 Therapeutics, Inc. Stake · Menlo Park, California
- Annexon, Inc. Stake · Brisbane, California
- Aravive, Inc. Stake · Menlo Park, California, United States
- Arcus Biosciences Stake · Hayward
- ASLAN Pharmaceuticals Ltd Stake · Singapore, Singapore
- Avalo Therapeutics, Inc. Stake · Wayne, Pennsylvania
- Calithera Biosciences, Inc. Stake · South San Francisco, California, United States
- Calliditas Therapeutics AB Stake · V7
- Celcuity Inc. Stake · Minneapolis, Minnesota, United States
- Centessa Pharmaceuticals plc Stake · Altrincham, United Kingdom
- Cidara Therapeutics Stake · San Diego, California, United States
- Cogent Biosciences, Inc. Stake · Waltham, Massachusetts
- Compass Therapeutics, Inc. Stake · Boston, Massachusetts
- CONCERT PHARMACEUTICALS, INC. Stake · Lexington, Massachusetts
- CONTRAFECT Corp Stake · Yonkers, New York, United States
- Corvus Pharmaceuticals, Inc. Stake · Burlingame, California, United States
- CRESCENT BIOPHARMA, INC. Stake · Waltham, Massachusetts
- Crinetics Pharmaceuticals Stake · San Diego, California, United States
- and 81 more
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (106 companies). Each entity in the chart links to its source.
Leadership
Named in SEC Form D filings
People the company listed in its private-offering notices.
Filings
5 filings to the SEC since October 2021: 5 private raises. The latest 5:
- Dec 23, 2025D/A EDGAR
- Dec 27, 2024D/A EDGAR
- Dec 29, 2023D/A EDGAR
- Dec 30, 2022D/A EDGAR
- Jan 4, 2022D/A EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
BIOTECHNOLOGY VALUE FUND L P has told the SEC it owns more than 5% of 106 companies, latest first (Schedules 13D and 13G).
- Foghorn Therapeutics Inc.SCHEDULE 13G/A May 30, 2024 to Oct 5, 20263
- Stoke Therapeutics, Inc.SCHEDULE 13G Sep 30, 20264
- Tyra Biosciences, Inc.SCHEDULE 13G Mar 24, 2022 to Sep 21, 20265
- Alector (United States)SCHEDULE 13G Sep 18, 20266
- Avalo Therapeutics, Inc.SCHEDULE 13G/A Aug 23, 2024 to Aug 14, 20267
- Cullinan OncologySCHEDULE 13G/A Nov 8, 2021 to Aug 14, 20268
- ImageneBio, Inc.SCHEDULE 13G/A Feb 14, 2022 to Aug 14, 20269
- Invivyd, Inc.SCHEDULE 13G/A Oct 22, 2025 to Aug 14, 202610
- Nektar TherapeuticsSCHEDULE 13G/A Jul 9, 2025 to Aug 14, 202611
- OnKure Therapeutics, Inc.SCHEDULE 13G/A May 27, 2026 to Aug 14, 202612
- PALVELLA THERAPEUTICS, INC.SCHEDULE 13G/A Feb 14, 2022 to Aug 14, 202613
- TENAX THERAPEUTICS, INC.SCHEDULE 13G/A Aug 19, 2024 to Aug 14, 202614
- TScan Therapeutics, Inc.SCHEDULE 13G/A Jun 5, 2023 to Aug 14, 202615
- TCGX Acquisition Corp.SCHEDULE 13G Aug 12, 202616
- Entera Bio Ltd.SCHEDULE 13D Aug 4, 202617
- Research Alliance Corp IVSCHEDULE 13G Jul 20, 202618
- XOMA Royalty CorpSCHEDULE 13D/A Jan 16, 2024 to Jul 16, 202619
- Pyxis Oncology, Inc.SCHEDULE 13G Dec 20, 2021 to Jul 10, 202620
- MoonLake ImmunotherapeuticsSCHEDULE 13D/A Apr 18, 2022 to Jun 29, 202621
- Kymera TherapeuticsSCHEDULE 13D/A Jan 31, 2022 to Jun 26, 202622
- Q32 Bio Inc.SCHEDULE 13G Jun 4, 202623
- Research Alliance Corp IIISCHEDULE 13G May 29, 202624
- 4D Molecular Therapeutics, Inc.SCHEDULE 13G/A Jun 21, 2022 to May 15, 202625
- Annexon, Inc.SCHEDULE 13G/A May 26, 2022 to May 15, 202626
- Compass Therapeutics, Inc.SCHEDULE 13G/A Oct 29, 2025 to May 15, 202627
- Eledon Pharmaceuticals, Inc.SCHEDULE 13G/A Jan 11, 2022 to May 15, 202628
- Monte Rosa TherapeuticsSCHEDULE 13G/A Jan 31, 2025 to May 15, 202629
- IMMUNIC, INC.SCHEDULE 13D Jan 18, 2024 to Feb 20, 202630
- Sutro BiopharmaSCHEDULE 13G Jan 18, 2022 to Feb 18, 202631
- SAB Biotherapeutics, Inc.SCHEDULE 13G/A Dec 4, 2023 to Feb 17, 202632
All 106 companies
- Septerna, Inc.SCHEDULE 13G/A Nov 1, 2024 to Feb 17, 202633
- Structure Therapeutics Inc.SCHEDULE 13G/A Feb 13, 2023 to Feb 17, 202634
- X4 Pharmaceuticals, IncSCHEDULE 13G/A Feb 14, 2022 to Feb 17, 202635
- Xencor IncSCHEDULE 13G/A Oct 17, 2025 to Feb 17, 202636
- Repare Therapeutics Inc.SCHEDULE 13D/A Feb 14, 2022 to Jan 30, 202637
- Inventiva S.A.SCHEDULE 13D/A Sep 25, 2023 to Nov 19, 202538
- Celcuity Inc.SCHEDULE 13G/A Jun 10, 2024 to Nov 14, 202539
- Forte Biosciences, Inc.SCHEDULE 13G/A Feb 14, 2022 to Nov 14, 202540
- Kura OncologySCHEDULE 13G/A Dec 5, 2022 to Nov 14, 202541
- Mirum PharmaceuticalsSCHEDULE 13G/A Sep 18, 2023 to Nov 14, 202542
- Protagonist Therapeutics, IncSCHEDULE 13G/A Feb 14, 2022 to Nov 14, 202543
- RAPT Therapeutics, Inc.SCHEDULE 13G/A Jan 6, 2025 to Nov 14, 202544
- ZymeworksSCHEDULE 13G/A Jan 3, 2023 to Nov 14, 202545
- NewcelX Ltd.SCHEDULE 13G/A Dec 16, 2022 to Nov 4, 202546
- Cidara TherapeuticsSCHEDULE 13G/A Dec 16, 2021 to Oct 17, 202547
- Essa Pharma (United States)SCHEDULE 13D/A Feb 14, 2022 to Oct 14, 202548
- CRESCENT BIOPHARMA, INC.SCHEDULE 13G/A Jan 29, 2024 to Aug 14, 202549
- Unicycive Therapeutics, Inc.SCHEDULE 13G/A Jul 6, 2023 to Aug 14, 202550
- Verve Therapeutics, Inc.SCHEDULE 13G/A Nov 18, 2024 to Aug 14, 202551
- Vigil Neuroscience, Inc.SCHEDULE 13G/A Aug 26, 2022 to Aug 14, 202552
- iTeos Therapeutics, Inc.SCHEDULE 13G/A May 2, 2022 to Aug 14, 202553
- Verastem OncologySCHEDULE 13G/A Jan 10, 2022 to Aug 13, 202554
- Ovid Therapeutics Inc.SCHEDULE 13G/A Feb 14, 2023 to Jul 21, 202555
- CytomX Therapeutics, Inc.SCHEDULE 13G/A Jan 3, 2022 to Jul 9, 202556
- Allakos Inc.SCHEDULE 13G/A Sep 29, 2022 to May 19, 202557
- Elevation Oncology, Inc.SCHEDULE 13G/A Feb 14, 2022 to May 15, 202558
- GH Research PLCSCHEDULE 13G/A Feb 14, 2022 to May 15, 202559
- Third Harmonic Bio, Inc.SCHEDULE 13G/A Sep 26, 2022 to Apr 16, 202560
- 89bio, Inc.SCHEDULE 13G/A Jul 11, 2022 to Feb 14, 202561
- Vistagen Therapeutics, Inc.SCHEDULE 13G/A Oct 16, 2023 to Feb 14, 202562
- enGene Therapeutics Inc.SCHEDULE 13G/A Nov 13, 2023 to Jan 29, 202563
- Olema Pharmaceuticals, Inc.SC 13D/A Dec 2, 2021 to Dec 4, 202464
- AC Immune SASC 13G/A Feb 14, 2022 to Nov 14, 202465
- AN2 Therapeutics, Inc.SC 13G/A Apr 4, 2022 to Nov 14, 202466
- Centessa Pharmaceuticals plcSC 13G/A Jun 16, 2022 to Nov 14, 202467
- Delcath Systems, Inc.SC 13G/A Jun 22, 2023 to Nov 14, 202468
- Ideaya Biosciences (United States)SC 13G/A Feb 14, 2022 to Nov 14, 202469
- Janux Therapeutics, Inc.SC 13G/A May 30, 2023 to Nov 14, 202470
- Lexicon PharmaceuticalsSC 13G/A Feb 14, 2022 to Nov 14, 202471
- Molecular Templates, Inc.SC 13G/A Feb 14, 2022 to Nov 14, 202472
- Regulus Therapeutics Inc.SC 13G/A Feb 14, 2022 to Nov 14, 202473
- Viracta Therapeutics, Inc.SC 13G/A Feb 14, 2022 to Nov 14, 202474
- Molecular PartnersSC 13D/A Jan 12, 2022 to Oct 29, 202475
- Calliditas Therapeutics ABSC 13G/A Feb 14, 2023 to Sep 11, 202476
- ASLAN Pharmaceuticals LtdSC 13G/A Mar 6, 2023 to Feb 14, 202477
- Aclaris Therapeutics, Inc.SC 13G/A Jan 24, 2022 to Feb 14, 202478
- Aravive, Inc.SC 13G/A Nov 7, 2022 to Feb 14, 202479
- Crinetics PharmaceuticalsSC 13G/A Oct 29, 2021 to Feb 14, 202480
- Galmed Pharmaceuticals Ltd.SC 13G/A Feb 14, 2023 to Feb 14, 202481
- Jasper Therapeutics, Inc.SC 13G/A Feb 6, 2023 to Feb 14, 202482
- Merus N.V.SC 13G/A Feb 14, 2022 to Feb 14, 202483
- Neuphoria Therapeutics Inc.SC 13G/A Feb 14, 2022 to Feb 14, 202484
- Rein Therapeutics, Inc.SC 13G/A Feb 14, 2023 to Feb 14, 202485
- Revolution Medicines (United States)SC 13G/A Feb 14, 2022 to Feb 14, 202486
- Viridian Therapeutics, Inc.\DESC 13G/A Feb 14, 2022 to Feb 14, 202487
- Rain Oncology Inc.SC 13D/A Jan 11, 2022 to Jan 29, 202488
- POINT Biopharma Global Inc.SC 13D/A Feb 14, 2022 to Dec 20, 202389
- CTI BioPharmaSC 13D/A Aug 11, 2022 to Jun 28, 202390
- Alpine Immune SciencesSC 13G/A Feb 14, 2022 to Feb 14, 202391
- Arcus BiosciencesSC 13G/A Mar 14, 2022 to Feb 14, 202392
- CONCERT PHARMACEUTICALS, INC.SC 13G/A Nov 15, 2021 to Feb 14, 202393
- Calithera Biosciences, Inc.SC 13G/A Feb 14, 202394
- Cogent Biosciences, Inc.SC 13G/A Feb 14, 2022 to Feb 14, 202395
- PHAXIAM Therapeutics S.A.SC 13G/A Feb 14, 2022 to Feb 14, 202396
- RELMADA THERAPEUTICS, INC.SC 13G/A Dec 20, 2021 to Feb 14, 202397
- Spero Therapeutics, Inc.SC 13G/A Feb 14, 2022 to Feb 14, 202398
- Syndax Pharmaceuticals IncSC 13G/A Feb 14, 2022 to Feb 14, 202399
- Xenon PharmaceuticalsSC 13G/A Feb 14, 2022 to Feb 14, 2023100
- CONTRAFECT CorpSC 13G/A Jul 19, 2022101
- Corvus Pharmaceuticals, Inc.SC 13G/A Feb 14, 2022102
- Forward Pharma A/SSC 13G/A Feb 14, 2022103
- Genocea (United States)SC 13G/A Feb 14, 2022104
- Gritstone bio, Inc.SC 13G/A Feb 14, 2022105
- INFINITY PHARMACEUTICALS, INC.SC 13G/A Feb 14, 2022106
- Selecta Biosciences (United States)SC 13G/A Feb 14, 2022107
- Whitehawk Therapeutics, Inc.SC 13G/A Feb 14, 2022108
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- Private raises (Form D) $1.6B
Figures by year
| Year | Private raises (Form D) | Total |
|---|---|---|
| 2008 | $1.6B | $1.6B |
Private raises
Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108